Covetrus Financial Statements () |
||||||||||
Covetrussmart-lab.ru | % | 2019 | 2020 | 2021 | LTM ? | |||||
---|---|---|---|---|---|---|---|---|---|---|
Report date | 03.03.2020 | 01.03.2021 | 30.09.2021 | 28.02.2022 | 30.06.2022 | 04.08.2022 | ||||
Currency | USD | USD | USD | USD | USD | USD | ||||
Financial report URL | ||||||||||
Revenue, bln rub | ? | 3 976 | 4 339 | 4 575 | 4 649 | |||||
Operating Income, bln rub | -997.0 | -69.0 | -22.0 | 4.00 | ||||||
EBITDA, bln rub | ? | -794.0 | 211.0 | 178.0 | 198.0 | |||||
Net profit, bln rub | ? | -1 019 | -19.0 | -86.0 | -13.0 | |||||
OCF, bln rub | ? | 103.0 | 53.0 | 102.0 | 64.0 | |||||
CAPEX, bln rub | ? | 39.0 | 58.0 | 60.0 | 62.0 | |||||
FCF, bln rub | ? | 64.0 | -5.00 | 42.0 | 2.00 | |||||
Dividend payout, bln rub | 0.000 | 0.000 | 0.000 | 0.000 | ||||||
Ordinary share dividend yield, % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | ||||
Dividend payout ratio, % | 0.00% | 0.00% | 0.00% | 0.00% | ||||||
OPEX, bln rub | 808.0 | 867.0 | 881.0 | 883.0 | ||||||
Cost of production, bln rub | 3 227 | 3 541 | 3 717 | 3 767 | ||||||
R&D, bln rub | 0.000 | 0.000 | 0.000 | 0.000 | ||||||
Interest expenses, bln rub | 56.0 | 47.0 | 32.0 | 28.0 | ||||||
Assets, bln rub | 3 361 | 3 496 | 3 420 | 3 410 | 3 398 | 3 398 | ||||
Net Assets, bln rub | ? | 1 256 | 1 537 | 1 502 | 1 511 | 1 505 | 1 505 | |||
Debt, bln rub | 1 187 | 1 069 | 1 073 | 1 046 | 1 049 | 1 049 | ||||
Cash, bln rub | 130.0 | 290.0 | 187.0 | 183.0 | 87.0 | 87.0 | ||||
Net debt, bln rub | 1 057 | 779.0 | 886.0 | 863.0 | 962.0 | 962.0 | ||||
Ordinary share price, rub | 13.2 | 28.7 | 18.1 | 20.0 | 20.8 | 20.8 | ||||
Number of ordinary shares, mln | 107.0 | 118.0 | 137.0 | 140.0 | ||||||
Market cap, bln rub | 1 412 | 3 391 | 0 | 2 736 | 0 | 2 905 | ||||
EV, bln rub | ? | 2 469 | 4 170 | 886 | 3 599 | 962 | 3 867 | |||
Book value, bln rub | -541 | -205 | -224 | -175 | -143 | -143 | ||||
EPS, rub | ? | -9.52 | -0.16 | -0.63 | -0.09 | |||||
FCF/share, rub | 0.60 | -0.04 | 0.31 | 0.01 | ||||||
BV/share, rub | -5.06 | -1.74 | -1.28 | -1.02 | ||||||
EBITDA margin, % | ? | -20.0% | 4.86% | 3.89% | 4.26% | |||||
Net margin, % | ? | -25.6% | -0.44% | -1.88% | -0.28% | |||||
FCF yield, % | ? | 4.53% | -0.15% | 0.00% | 1.54% | 0.00% | 0.07% | |||
ROE, % | ? | -81.1% | -1.24% | 0.00% | -5.69% | 0.00% | -0.86% | |||
ROA, % | ? | -30.3% | -0.54% | 0.00% | -2.52% | 0.00% | -0.38% | |||
P/E | ? | -1.39 | -178.5 | -31.8 | -223.5 | |||||
P/FCF | 22.1 | -678.3 | 65.1 | 1 453 | ||||||
P/S | ? | 0.36 | 0.78 | 0.60 | 0.62 | |||||
P/BV | ? | -2.61 | -16.5 | 0.00 | -15.6 | 0.00 | -20.3 | |||
EV/EBITDA | ? | -3.11 | 19.8 | 20.2 | 19.5 | |||||
Debt/EBITDA | -1.33 | 3.69 | 4.85 | 4.86 | ||||||
R&D/CAPEX, % | 0.00% | 0.00% | 0.00% | 0.00% | ||||||
CAPEX/Revenue, % | 0.98% | 1.34% | 1.31% | 1.33% | ||||||
Covetrus shareholders |